These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32670888)

  • 41. Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study.
    Guo L; Zheng J; Luo J; Zhang Z; Shao G
    Onco Targets Ther; 2020; 13():11071-11087. PubMed ID: 33149619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma.
    Yoshida S; Kornek M; Ikenaga N; Schmelzle M; Masuzaki R; Csizmadia E; Wu Y; Robson SC; Schuppan D
    Hepatology; 2013 Nov; 58(5):1667-80. PubMed ID: 23729316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of an insufficient radiofrequency ablation orthotopic nude mouse model of hepatocellular carcinoma to study the invasiveness and metastatic potential of residual cancer.
    Zhang N; Zhu H; Dong YH; Wang L
    Oncol Lett; 2019 Sep; 18(3):2548-2553. PubMed ID: 31402950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
    Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
    Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advantage of sorafenib combined with radiofrequency ablation for treatment of hepatocellular carcinoma.
    Tang Z; Kang M; Zhang B; Chen J; Fang H; Ye Q; Jiang B; Wu Y
    Tumori; 2017 May; 103(3):286-291. PubMed ID: 28058713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of Transducin-Like Enhancer of Split protein 4 in hepatocellular carcinoma promotes cell proliferation and epithelial-Mesenchymal-Transition.
    Wu XC; Xiao CC; Li H; Tai Y; Zhang Q; Yang Y
    Biochem Biophys Res Commun; 2016 Aug; 477(2):161-6. PubMed ID: 27297112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma.
    Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z
    Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Teng W; Liu KW; Lin CC; Jeng WJ; Chen WT; Sheen IS; Lin CY; Lin SM
    Liver Cancer; 2015 Mar; 4(1):26-38. PubMed ID: 26020027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma.
    Xie H; Tian S; Yu H; Yang X; Liu J; Wang H; Feng F; Guo Z
    Onco Targets Ther; 2018; 11():3257-3265. PubMed ID: 29910621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.
    Wu Y; Liu H; Weng H; Zhang X; Li P; Fan CL; Li B; Dong PL; Li L; Dooley S; Ding HG
    Int J Oncol; 2015 Mar; 46(3):1275-85. PubMed ID: 25572615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.
    Prieto-Domínguez N; Ordóñez R; Fernández A; Méndez-Blanco C; Baulies A; Garcia-Ruiz C; Fernández-Checa JC; Mauriz JL; González-Gallego J
    J Pineal Res; 2016 Oct; 61(3):396-407. PubMed ID: 27484637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GC7 blocks epithelial-mesenchymal transition and reverses hypoxia-induced chemotherapy resistance in hepatocellular carcinoma cells.
    Zhou QY; Tu CY; Shao CX; Wang WK; Zhu JD; Cai Y; Mao JY; Chen W
    Am J Transl Res; 2017; 9(5):2608-2617. PubMed ID: 28560008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
    Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
    Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma.
    Seo SH; Cho KJ; Park HJ; Kim H; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    Am J Cancer Res; 2021; 11(10):4788-4806. PubMed ID: 34765293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy.
    Wu JM; Sheng H; Saxena R; Skill NJ; Bhat-Nakshatri P; Yu M; Nakshatri H; Maluccio MA
    Cancer Lett; 2009 Jun; 278(2):145-155. PubMed ID: 19303700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 60. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.